Havas ECS (Endocannabinoid Science)
Rob is an experienced communications executive, healthcare strategist, and leader of cross-functional teams. Rob and his Havas ECS colleagues serve to advance the understanding of cannabinoid health and wellness, with accredited science-based education and non-accredited communication programs that frame and elevate the “cannabinoid as medicine conversation”, to increase understanding of cannabinoid treatments and ECS-related medical conditions. Prior to leading Havas ECS, Rob’s experiences include life as a pharmaceutical marketer launching three new drugs, as a digital health entrepreneur , and as president of healthcare at DAS unit of Omnicom Group.